Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CP4071 in Previously Treated Advanced Sarcomas
NCT00017446Phase 2Unknown
- Sponsor
- Herbert Irving Comprehensive Cancer Center
- Start
- Oct 2000
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of digitoxin in soft tissue sarcoma (STS), sponsored by Herbert Irving Comprehensive Cancer Center. Status: unknown.
02
Drugs
digitoxin
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00017446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00017446.